Media Home
UN Web TV
UN Audiovisual Library
UN PhotoUnifeed
GENEVA / STI GUIDELINES
STORY: GENEVA / STI GUIDELINES
TRT: 01:59
SOURCE: WHO
RESTRICTIONS: NONE
LANGUAGE: ENGLISH / FRENCH / NATS
DATELINE: 30 AUGUST 2016, GENEVA, SWITZERLAND
RECENT, GENEVA, SWITZERLAND
1. Wide shot, exterior WHO Headquarters
30 AUGUST 2016, GENEVA, SWITZERLAND
2. SOUNDBITE (English) Dr Teodora Wi, Medical Officer, Department of Reproductive Health and Research, World Health Organization (WHO):
“There are more than one million sexually transmitted infections occurring every day. It affects men, women, children, adolescents, everywhere in the globe.”
3. Med shot, Dr Teodora Wi and other officials talking
4. SOUNDBITE (English) Dr Teodora Wi, Medical Officer, Department of Reproductive Health and Research, World Health Organization (WHO):
“Correct treatment of sexually transmitted infections are very important to prevent antimicrobial resistance. WHO has just released new guidelines for gonorrhoea, chlamydia and syphilis, to prevent antimicrobial resistance and to encourage countries to make treatment available, especially treatments like benzidine, penicillin.”
5. Pan right, from Wi to Dr Nathalie Broutet
6. SOUNDBITE (French) Dr Nathalie Broutet, Medical Officer, Department of Reproductive Health and Research, World Health Organization (WHO):
"Every day, worldwide, there are more than one million new cases of sexually transmitted infections. These infections affect women, children, adolescents, men, and everyone everywhere in the world.”
7. Med shot, copy of the WHO report
8. SOUNDBITE (French) Dr Nathalie Broutet, Medical Officer, Department of Reproductive Health and Research, World Health Organization (WHO):
“These sexually transmitted infections have a significant impact on the health of women, children, adolescents, men everywhere in the world and they have an impact also on the well-being of the people.”
9. Close up, WHO report
10. SOUNDBITE (French) Dr Nathalie Broutet, Medical Officer, Department of Reproductive Health and Research, World Health Organization (WHO):
“The correct treatment of these sexually transmitted infections is essential to control and reduce resistance to antibiotics. WHO has developed guidelines for the correct treatment and encourages countries to adapt these new treatments and ensure that these treatments are available especially for the treatment of the gonorrhoea and treatment of syphilis in pregnant women.”
11. Zoom in, from official to report
New guidelines for the treatment of three common sexually transmitted infections (STIs) have been issued by the World Health Organization (WHO) in response to the growing threat of antibiotic resistance.
Chlamydia, gonorrhoea and syphilis are all caused by bacteria and they are generally curable with antibiotics. However, these STIs often go undiagnosed and they are becoming more difficult to treat, with some antibiotics now failing as a result of misuse and overuse. It is estimated that, each year, 131 million people are infected with chlamydia, 78 million with gonorrhoea, and 5.6 million with syphilis.
SOUNDBITE (English) Dr Teodora Wi, Medical Officer, Department of Reproductive Health and Research, World Health Organization (WHO):
“There are more than one million sexually transmitted infections occurring every day. It affects men, women, children, adolescents, everywhere in the globe.”
Resistance of these STIs to the effect of antibiotics has increased rapidly in recent years and has reduced treatment options. Of the three STIs, gonorrhoea has developed the strongest resistance to antibiotics. Strains of multidrug-resistant gonorrhoea that do not respond to any available antibiotics have already been detected. Antibiotic resistance in chlamydia and syphilis, though less common, also exists, making prevention and prompt treatment critical.
SOUNDBITE (English) Dr Teodora Wi, Medical Officer, Department of Reproductive Health and Research, World Health Organization (WHO):
“Correct treatment of sexually transmitted infections are very important to prevent antimicrobial resistance. WHO has just released new guidelines for gonorrhoea, chlamydia and syphilis, to prevent antimicrobial resistance and to encourage countries to make treatment available, especially treatments like benzidine, penicillin.”
Benzathine penicillin was recognized by the 69th World Health Assembly in May 2016 as an essential medicine which has been in short supply for several years. Reports of stock outs have been received by WHO from antenatal care representatives and providers in countries with high burdens of syphilis from three WHO Regions. WHO is working with partners to identify countries with shortages and help monitor global availability of benzathine penicillin to close the gap between national needs and supply of the antibiotic.
SOUNDBITE (French) Dr Nathalie Broutet, Medical Officer, Department of Reproductive Health and Research, World Health Organization (WHO):
"Every day, worldwide, there are more than one million new cases of sexually transmitted infections. These infections affect women, children, adolescents, men, and everyone everywhere in the world.”
The new recommendations are based on the latest available evidence on the most effective treatments for these three sexually transmitted infections.
SOUNDBITE (French) Dr Nathalie Broutet, Medical Officer, Department of Reproductive Health and Research, World Health Organization (WHO):
“These sexually transmitted infections have a significant impact on the health of women, children, adolescents, men everywhere in the world and they have an impact also on the well-being of the people.”
When left undiagnosed and untreated, these STIs can result in serious complications and long-term health problems for women, such as pelvic inflammatory disease, ectopic pregnancy and miscarriage, and untreated gonorrhoea and chlamydia can cause infertility in both men and women. Infection with chlamydia, gonorrhoea and syphilis can also increase a person’s risk of being infected with HIV two to three fold. An untreated STI in a pregnant woman increases the chances of stillbirth and new-born death.
SOUNDBITE (French) Dr Nathalie Broutet, Medical Officer, Department of Reproductive Health and Research, World Health Organization (WHO):
“The correct treatment of these sexually transmitted infections is essential to control and reduce resistance to antibiotics. WHO has developed guidelines for the correct treatment and encourages countries to adapt these new treatments and ensure that these treatments are available especially for the treatment of the gonorrhoea and treatment of syphilis in pregnant women.”
Gonorrhoea is a common STI that can cause infection in the genitals, rectum, and throat. Antimicrobial resistance has appeared and expanded with every release of new classes of antibiotics for the treatment of gonorrhoea. Because of widespread resistance, older and cheaper antibiotics have lost their effectiveness in treatment of the infection.
Syphilis is spread by contact with a sore on the genitals, anus, rectum, lips or mouth, or from mother to child during pregnancy. If a pregnant woman has untreated syphilis and the infection is transmitted to the fetus, this often causes it to die. In 2012, mother-to-child transmission of syphilis resulted in an estimated 143 000 early fetal deaths/stillbirths, 62 000 neonatal deaths and 44 000 babies being born preterm/low-birth-weight.
Chlamydia is the most common bacterial STI and people with this infection are frequently co-infected with gonorrhoea. Symptoms of chlamydia include discharge and a burning feeling when urinating, but most people who are infected have no symptoms. Even when chlamydia is asymptomatic, it can damage the reproductive system.
Download
There is no media available to download.
